收藏切换
Progress in the development of conjugate vaccines using innovative technologies
收藏切换
Xiang LI, Rui-hao LIU, Wen-hua HUANG, Heng-liang WANG*, Li ZHU*
Acta Pharmaceutica Sinica | 2025, 60(7) : 1991 - 2001
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(7): 1991-2001
• Special Reports: Research progress and development trend of carbohydrate-based vaccines •
Progress in the development of conjugate vaccines using innovative technologies
Full
Xiang LI, Rui-hao LIU, Wen-hua HUANG, Heng-liang WANG*, Li ZHU*
Affiliations
  • State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100071, China
Published: 2025-07-12 doi: 10.16438/j.0513-4870.2025-0353
Outline
收藏切换

Glycoconjugate vaccines are essential tools for preventing bacterial infectious diseases. Currently licensed glycoconjugate vaccines are produced through a stepwise process that involves the extraction of native polysaccharide antigens, purification of carrier proteins, and subsequent in vitro chemical conjugation. In recent years, the rapid advancement of emerging technologies such as synthetic biology has driven the development of innovative strategies for designing and manufacturing glycoconjugate vaccines. This review highlights progress in two representative technologies: protein glycan coupling technology (PGCT) and cell-free glycoprotein synthesis (CFGpS). It also briefly explores additional emerging approaches in glycoconjugate vaccine development, including generalized modules for membrane antigens (GMMA), semi-synthetic glycoconjugate vaccines, non-covalent coupling strategies, and click chemistry-based conjugation using non-natural amino acids. Looking ahead, advancements in artificial intelligence (AI) are expected to accelerate the computational design and engineering of oligosac-charyltransferases and carrier proteins, ultimately improving the immunogenicity and manufacturing efficiency of next-generation glycoconjugate vaccines.

glycoconjugate vaccine  /  synthetic biology  /  protein glycan coupling technology  /  cell-free glycoprotein synthesis  /  generalized modules for membrane antigen
李湘, 刘睿昊, 黄文华, 王恒樑, 朱力. 创新技术在多糖结合疫苗研发中的应用进展. 药学学报, 2025 , 60 (7) : 1991 -2001 . DOI: 10.16438/j.0513-4870.2025-0353
Xiang LI, Rui-hao LIU, Wen-hua HUANG, Heng-liang WANG, Li ZHU. Progress in the development of conjugate vaccines using innovative technologies[J]. Acta Pharmaceutica Sinica, 2025 , 60 (7) : 1991 -2001 . DOI: 10.16438/j.0513-4870.2025-0353
Year 2025 volume 60 Issue 7
330
158
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0353
  • Receive Date:2025-03-29
  • Online Date:2026-09-20
  • Published:2025-07-12
Article Data
Affiliations
History
  • Received:2025-03-29
  • Revised:2025-05-14
Affiliations
    State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100071, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0353
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT